NIH expands network focused on how genes affect drug responses, September 7, News Release - National Institutes of Health (NIH)

"...Spearheaded by the NIH's National Institute of General Medical Sciences (NIGMS) and launched in 2000, the PGRN has already identified gene variants linked to responses to medicines for different cancers, heart disease, asthma, nicotine addiction and other conditions...."cont'd